- WHATS NEW?
- Suppression of chemokines by HDL
- HDL cholesterol linked to oestrogen levels
- New gene loci regulating HDL cholesterol identified
- Abnormal lipids when young predicts atherosclerosis in later life
- JUPITER: Is HDL cholesterol relevant to residual risk in low-risk patients on potent statin therapy?
- EAS Workshop: How does HDL protect against atherosclerosis?
Mixed results with LY518674, novel therapy for lipid disorders
LY518674, a novel, potent peroxisome proliferator- activated receptor
alpha (PPAR-alpha) agonist, showed no advantages compared with
fenofibrate, in clinical studies.
Corporate sponsor
